News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Smith & Nephew Inc. Q3 Falls Short, Buybacks on Hold
November 6, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, Nov 6 (Reuters) - Europe's biggest medical device company Smith & Nephew posted third-quarter earnings short of analyst forecasts on Thursday and suspended share buybacks, sending its stock sharply lower.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Layoff Tracker
LENZ cuts 75% of staff as third quarter earnings disappoint
October 29, 2026
·
111 min read
·
BioSpace Editorial Staff
Neuroscience
Ono cans 2 endocannabinoid drug studies after quintuple Phase 2 failure
October 29, 2026
·
1 min read
·
Annalee Armstrong
Earnings
Lilly can’t stop, won’t stop as revenue climbs 39% thanks to GLP-1 bestsellers
October 29, 2026
·
1 min read
·
Annalee Armstrong
Insights
Stability, speed and strategy: Inside Australia’s early‑stage edge
October 29, 2026
·
1 min read
·
Jennifer C. Smith-Parker
